F. Laurent

Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study

J. Breeze, M. Dimopoulos, R. Vij, 2021, BMC cancer.

Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study

J. Shah, J. Breeze, M. Dimopoulos, 2020, BMC Cancer.

[Quality of life in chronic inflammatory bowel diseases. Validation of a questionnaire and first French data].

Y. Yazdanpanah, P. Marquis, J. Colombel, 1996, Gastroentérologie Clinique et Biologique.